Compare MRNA & KIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRNA | KIM |
|---|---|---|
| Founded | 2010 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 13.6B |
| IPO Year | 2018 | 1991 |
| Metric | MRNA | KIM |
|---|---|---|
| Price | $51.78 | $20.77 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 14 |
| Target Price | ★ $32.75 | $24.14 |
| AVG Volume (30 Days) | ★ 11.8M | 4.3M |
| Earning Date | 02-13-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 4.97% |
| EPS Growth | N/A | ★ 57.13 |
| EPS | N/A | ★ 0.83 |
| Revenue | ★ $2,232,000,000.00 | $2,123,057,000.00 |
| Revenue This Year | N/A | $5.35 |
| Revenue Next Year | $3.18 | $3.17 |
| P/E Ratio | ★ N/A | $25.15 |
| Revenue Growth | N/A | ★ 8.14 |
| 52 Week Low | $22.28 | $17.93 |
| 52 Week High | $50.00 | $23.65 |
| Indicator | MRNA | KIM |
|---|---|---|
| Relative Strength Index (RSI) | 82.55 | 54.15 |
| Support Level | $39.21 | $20.25 |
| Resistance Level | $41.98 | $21.15 |
| Average True Range (ATR) | 2.93 | 0.38 |
| MACD | 1.57 | 0.06 |
| Stochastic Oscillator | 87.75 | 61.86 |
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
One of the oldest real estate investment trusts in the United States, Kimco Realty owns interests in 567 shopping centers throughout major markets in the US, representing roughly 101 million square feet.